Table 4.
1–10 -year cumulative risk | >10–21 -year cumulative risk | |||||
---|---|---|---|---|---|---|
BPH cohort% (95% CI) | Comparison cohort% (95% CI) | Adjusted* HR (95% CI) | BPH cohort% (95% CI) | Comparison cohort% (95% CI) | Adjusted* HR (95% CI) | |
History of cardiovascular disease | ||||||
Yes | 3.40 (3.24–3.57) | 3.06 (2.96–3.16) | 1.17 (1.11–1.24) | 4.32 (3.65–5.07) | 3.51 (3.17–3.87) | 1.16 (1.01–1.33) |
No | 2.40 (2.33–2.48) | 1.95 (1.91–1.98) | 1.19 (1.15–1.23) | 3.79 (3.48–4.11) | 2.97 (2.82–3.12) | 1.17 (1.10–1.23) |
History of diabetes | ||||||
Yes | 2.91 (2.64–3.21) | 2.70 (2.52–2.89) | 1.17 (1.04–1.32) | 5.03 (2.22–9.56) | 3.20 (2.57–3.94) | 1.15 (0.85–1.55) |
No | 2.59 (2.53–2.66) | 2.11 (2.07–2.14) | 1.19 (1.15–1.22) | 3.83 (3.55–4.13) | 3.01 (2.87–3.16) | 1.17 (1.11–1.23) |
History of hyperlipidemia | ||||||
Yes | 2.31 (2.01–2.63) | 2.32 (2.13–2.53) | 1.02 (0.88–1.19) | 3.56 (2.40–5.07) | 4.50 (3.20–6.11) | 0.85 (0.59–1.24) |
No | 2.63 (2.56–2.70) | 2.13 (2.09–2.16) | 1.19 (1.16–1.23) | 3.85 (3.57–4.16) | 3.00 (2.87–3.14) | 1.17 (1.11–1.24) |
History of hypertension | ||||||
Yes | 2.74 (2.55–2.93) | 2.75 (2.61–2.89) | 1.09 (1.00–1.18) | 2.84 (2.32–3.45) | 3.13 (2.48–3.88) | 1.08 (0.86–1.35) |
No | 2.60 (2.53–2.67) | 2.08 (2.04–2.11) | 1.20 (1.16–1.24) | 3.91 (3.62–4.23) | 3.01 (2.87–3.16) | 1.17 (1.11–1.24) |
History of chronic obstructive pulmonary disease | ||||||
Yes | 2.24 (2.02–2.47) | 2.19 (2.04–2.34) | 1.10 (0.98–1.24) | 3.61 (2.74–4.64) | 3.31 (2.46–4.34) | 1.23 (0.92–1.64) |
No | 2.64 (2.57–2.71) | 2.13 (2.10–2.17) | 1.19 (1.16–1.23) | 3.86 (3.57–4.16) | 3.01 (2.87–3.16) | 1.17 (1.10–1.23) |
*Adjusted for age, time period of diagnosis/index date, income and employment status in the year before index date, obesity, renal failure and the diseases presented in the table (except the stratifying variable). All included covariates were measured at the date of BPH diagnosis/index date.